Incidence, outcomes, and predictors of in-hospital acute coronary syndrome following endovascular transcatheter aortic valve replacement in the United States

Autor: Mubasshar A Syed, Keerat Rai Ahuja, Mujeeb Sheikh, Samir R. Kapadia, Robert D. Grande, Beni R Verma, Salik Nazir, Mohamed M. Gad, Khalid Hamid Changal, Anas M. Saad, Anthony A. Donato, P. Kasi Ramanathan
Rok vydání: 2019
Předmět:
Male
medicine.medical_specialty
Acute coronary syndrome
Time Factors
Databases
Factual

medicine.medical_treatment
Health Status
Comorbidity
030204 cardiovascular system & hematology
Patient Readmission
Risk Assessment
Transcatheter Aortic Valve Replacement
03 medical and health sciences
0302 clinical medicine
Valve replacement
Risk Factors
Internal medicine
medicine
Humans
Radiology
Nuclear Medicine and imaging

030212 general & internal medicine
Hospital Mortality
Acute Coronary Syndrome
Aged
Aged
80 and over

Frailty
business.industry
Cardiogenic shock
Incidence
Acute kidney injury
General Medicine
Odds ratio
Aortic Valve Stenosis
Length of Stay
medicine.disease
United States
Treatment Outcome
Heart failure
Cohort
Cardiology
Female
Cardiology and Cardiovascular Medicine
business
Kidney disease
Zdroj: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac AngiographyInterventionsREFERENCES. 96(5)
ISSN: 1522-726X
Popis: BACKGROUND Incidence and outcomes of acute coronary syndrome (ACS) immediately following transcatheter aortic valve replacement (TAVR) remain largely unknown. OBJECTIVES This study sought to assess the incidence, clinical characteristics, and outcomes of ACS following TAVR. METHODS We queried the National Readmission Database from January 2012 to September 2015 for TAVR admissions with and without ACS, creating a propensity-matched cohort to compare outcomes. RESULTS A total of 48,454 patients underwent TAVR, with 1,332 (2.75%) developing ACS. TAVR patients with ACS compared to those without ACS had a significantly higher incidence of acute kidney injury (24.7 vs. 19.2%; p = .001), ischemic stroke (3.7 vs. 2.3%; p = .04), vascular complications (8.6 vs. 5.8%; p = .008), cardiogenic shock (9.8 vs. 1.9%; p
Databáze: OpenAIRE